C. R. Bard, Inc. (NYSE: BCR)
Murray Hill, NJ 07974 (Map) Phone: 908-277-8000
Fax: 908-277-8412
Toll Free: 800-367-2273
http://www.crbard.com
Overview
C. R. Bard is no upstart in the world of medical devices. The company has been in the business for more than a century and introduced the Foley urological catheter (still one of its top sellers) in 1934. Its products fall into four general therapeutic categories: vascular, urology, oncology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; urology catheters and products used to treat urinary incontinence; and catheters for delivering chemotherapy treatments. Its line of specialty surgical tools, made by subsidiary Davol, includes devices used in laparoscopic and orthopedic procedures and for hernia repair.
Sample Overview & HistoryKey Numbers from Hoover's UK
Key financials for C. R. Bard, Inc. (NYSE: BCR)
| Company Type | Public (NYSE: BCR) |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | £1,758.3 |
| 1-Year Sales Growth | 7.3% |
| 2010 Net Income (mil.) | £329.1 |
| 1-Year Net Income Growth | 10.7% |
| 2010 Employees | 11,700 |
| 1-Year Employee Growth | 6.4% |
Key People from Hoover's UK
Key people and executives for C. R. Bard, Inc. (NYSE: BCR)
| Chairman and CEO | Timothy M. Ring (Subscribers see complete biographies -- view sample)
|
|---|---|
| President, COO, and Director | John H. Weiland |
| SVP and CFO | Todd C. Schermerhorn |
Top Competitors from Hoover's UK
Top competitors of C. R. Bard, Inc. (NYSE: BCR)
There are 23 competitors for Bard; see more.Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
More Industry InformationSubsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of C. R. Bard, Inc. (NYSE: BCR)
Rankings from Hoover's UK
See how C. R. Bard, Inc. (NYSE: BCR) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones
- S&P 500
- #704 in FORTUNE 1000 (May 2011)

